David Alfego
Biographic Data
| ID | 8340594 |
|---|---|
| NAME | David Alfego |
| GIVEN NAMES | David |
| FAMILY NAME | Alfego |
| SIGNATURE | ALFEGO D |
| AFFILIATIONS | LabCorp (United States) |
| ORCID | 0000-0002-0465-9131 |
| VERIFIED | Yes |
| TOTAL WORKS | 2 |
| TOTAL CITATIONS | 0 |
| AUTHOR COUNT | 2 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2021 |
| LATEST PUBLICATION YEAR | 2023 |
| H-INDEX | 0 |
Prevalence and trends in mono- and co-infection of Covid-19, influenza A/B, and respiratory syncytial virus, January 2018–June 2023
Objectives: This study aimed to determine the impact of the COVID-19 pandemic on the overall prevalence and co-infection rates for COVID-19, influenza A/B, and respiratory syncytial virus in a large national population. Methods: sites from January 2018 to June 2023, comparing positivity rates and co-infection rates by age, sex, and seasonality. Results: In 2021-2023, 1,232 (0.10%) tested positive for COVID-19 and influenza A/B, 366 (0.03%) tested…
Follow-Up Sars-CoV-2 PCR Testing Outcomes From a Large Reference Lab in the US
By analyzing COVID-19 sequential COVID-19 test results of patients across the United States, we herein attempt to quantify some of the observations we've made around long-term infection (and false-positive rates), as well as provide observations on the uncertainty of sampling variability and other dynamics of COVID-19 infection in the United States. Retrospective cohort study of a registry of RT-PCR testing results for all patients tested at any …
No prominent works on this page.
Follow-Up Sars-CoV-2 PCR Testing Outcomes From a Large Reference Lab in the US
By analyzing COVID-19 sequential COVID-19 test results of patients across the United States, we herein attempt to quantify some of the observations we've made around long-term infection (and false-positive rates), as well as provide observations on the uncertainty of sampling variability and other dynamics of COVID-19 infection in the United States. Retrospective cohort study of a registry of RT-PCR testing results for all patients tested at any …
Prevalence and trends in mono- and co-infection of Covid-19, influenza A/B, and respiratory syncytial virus, January 2018–June 2023
Objectives: This study aimed to determine the impact of the COVID-19 pandemic on the overall prevalence and co-infection rates for COVID-19, influenza A/B, and respiratory syncytial virus in a large national population. Methods: sites from January 2018 to June 2023, comparing positivity rates and co-infection rates by age, sex, and seasonality. Results: In 2021-2023, 1,232 (0.10%) tested positive for COVID-19 and influenza A/B, 366 (0.03%) tested…
COVID-19 Clinical Research Studies (2 works) · Disease (2 works) · Internal Medicine (2 works) · Medicine (2 works) · SARS-CoV-2 detection and testing (2 works) · Biology (1 works) · Cohort (1 works) · Cohort study (1 works) · Demography (1 works) · Environmental health (1 works)